This study includes two parts (Single Ascending Dose, SAD; Multiple-Ascending Dose, MAD) and
enrolls healthy participants. Participants in SAD accept single subcutaneous (SC) injection
of HS-20094 and participants in MAD accept SC injection of HS-20094 once weekly for 4 weeks.
The main purpose of this study is to determine 1) The safety of HS-20094; 2) How much
HS-20094 gets into the bloodstream and how long it takes the body to get rid of it.3) How
HS-20094 affects the levels of blood sugar, insulin and weight.